I see that this basket trial is for 30 patients being injected with 350. Do you think we will have to do 30 patients at 500 and 700 as well? My hope is that with significant results at 350, they rush to BTD and approval right behind. I think this is a long shot and I'm hoping the FDA would not drag the trials out when thousands of people could have access very quickly with no SAEs